NCT02518984

Brief Summary

Given the advances in Atrial Fibrillation (AF) management and the availability of new European Society of Cardiology (ESC) guidelines, there is a need for the systematic collection of contemporary data regarding the management and treatment of AF in the member ESC countries. It is now nearly 10 years since the last European registry of AF management was undertaken (as part of the ESC Euro Heart Survey programme), and a new registry was needed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19,754

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

April 16, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 10, 2015

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

May 15, 2020

Status Verified

May 1, 2020

Enrollment Period

5.8 years

First QC Date

April 16, 2015

Last Update Submit

May 14, 2020

Conditions

Atrial Fibrillation

Outcome Measures

Primary Outcomes (1)

  • vital status

    Baseline

Other Outcomes (3)

  • vital status

    one year follow-up

  • vital status

    two year follow-up

  • vital status

    three year follow-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Out patients with AF and patients with acute pre-existing or new onset AF

You may qualify if:

  • Patients will be officially enrolled in the study only if ECG diagnosis of AF has been made.
  • The qualifying episode of AF should have occurred within one year before the date of baseline.
  • AF is the primary or secondary diagnosis, i.e. the current admission / visit may be due to other reasons.
  • Patients need not be in AF at the time of enrolment.
  • Signed Patient Inform Consent if applicable.

You may not qualify if:

  • No ECG/Holter with AF recorded.
  • Only atrial flutter recorded.
  • The qualifying episode of AF occurred more than one year before the date of baseline.
  • Age \<18 years.
  • Patients are already included in the ESC Atrial Fibrillation Long-Term registry if your centre was enrolled in the Pilot phase.
  • Patients who are currently or are planned to be taking part in a cardiac clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

European Society of Cardiology

Biot, 06903, France

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gregory Lip, MD

    European Society of Cardiology

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2015

First Posted

August 10, 2015

Study Start

October 1, 2013

Primary Completion

August 1, 2019

Study Completion

December 1, 2019

Last Updated

May 15, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)